FLINT, Mich., Aug. 24, 2016 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, chairman and CEO, and Sean Whelan, CFO, will present at four upcoming investor conferences.
- Robert W. Baird 2016 Healthcare Conference in New York on Wednesday, Sept. 7, 2016, at 10:50 a.m. ET
- Wells Fargo 2016 Healthcare Conference in Boston on Thursday, Sept. 8, 2016, at 10:30 a.m. ET
- Morgan Stanley Global Healthcare Conference in New York on Wednesday, Sept. 14, 2016, at 2:10 p.m. ET
- 7th Annual Credit Suisse Small/Mid Cap Conference in New York on Thursday, Sept. 15, 2016, at 8:10 a.m. ET
A live audio-only webcast of the Robert W. Baird 2016 Healthcare Conference presentation and related presentation materials will be available on the investor relations section of the Company's website at ir.diplomat.is. The archived webcast and presentation materials will also be available for 90 days at the same URL.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Bob East, Westwicke Partners
443.213.0500 | firstname.lastname@example.org
Jenny Cretu, Diplomat
810.768.9370 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-upcoming-investor-conferences-300317679.html